903P AL101 therapy in patients with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC): Final ACCURACY trial results and meta-analysis of clinical outcomes.

Saved in:
Bibliographic Details
Title: 903P AL101 therapy in patients with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC): Final ACCURACY trial results and meta-analysis of clinical outcomes.
Authors: Ferrarotto, R.1 (AUTHOR), Bobbili, P.2 (AUTHOR), Bowles, D.W.3 (AUTHOR), Even, C.4 (AUTHOR), Gordon, G.5 (AUTHOR), Gutierrez, A.6 (AUTHOR), Metcalf, R.7 (AUTHOR), Muzaffar, J.8 (AUTHOR), Nguyen, C.9 (AUTHOR), Oliva, M.10 (AUTHOR), Perez, C.A.11 (AUTHOR), Rodriguez, C.12 (AUTHOR), Sendhil, S.R.13 (AUTHOR), Winquist, E.14 (AUTHOR), Wirth, L.J.15 (AUTHOR), Xia, B.16 (AUTHOR), Yovell, J.17 (AUTHOR), Ho, A.L.18 (AUTHOR)
Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS575-S576. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2023.09.2048